GEMMABio

GEMMABio is a therapeutic drug company focused on advancing research and providing life-changing advanced therapies for patients with rare diseases. The company will offer research and product development capabilities to bring gene therapy discoveries from the bench to the bedside more quickly and cost-effectively. GEMMABio is led by gene therapy industry pioneer Jim Wilson and his team of experts, who previously conducted this work in academia. Wilson is also the chairman of Franklin Biolabs, a contract research organization that provides full-service offerings from discovery to clinical vector manufacturing for the global gene medicine industry.